Promising effective and safe Epstein-Barr virus (EBV) vaccine based on VLPs
Virus-like particles (VLPs) of EBV, completely devoid of viral DNA, for the prevention of infectious mononucleosis (IM) and EBV-associated diseases like lymphomas often developed in patients with immunosuppression.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
CO₂ Reduction in Exhaust Gases Breathes Life into Earth’s Climate
To protect the climate, the aim is to recover CO₂ from combustion processes for use as valuable materials. This is challenging because exhaust gases contain not only CO₂ but also…
Tailored Fitness Programs Linked to Increased Life Expectancy in Cancer Patients
Tailored exercise may prolong life in these patients, suggest researchers Muscular strength and good physical fitness are linked to a significantly lower risk of death from any cause in people…
Going Green: Fighting Freshwater Salt Pollution with Phytoremediation
Salt pollution in freshwater is a growing global concern. Excessive salt harms plants, degrades soil, and compromises water quality. In urban areas, road salts used for de-icing during winter often…